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ABSTRACT. A number of some main group and transition metal nicotine complexes were synthesized and 
fully characterized using detailed structural and spectroscopic analysis techniques such as elemental analysis, 
molar conductivities, magnetic susceptibilities, IR, Raman and NMR techniques. Moreover, scanning electron 
micrographs and thermogravimetric analyses were also done. Cytotoxic activities of the binary nicotine metal 
complexes were tested and evaluated against HepG2 (human hepatocellular carcinoma), HPC3 (human prostate 
cancer), and HCT116 (human colorectal carcinoma) tumor cell lines. The antioxidant activities were examined by 
free radical scavenging assay. The antimicrobial activities of the synthesized complexes were evaluated against 
Escherichia coli (gram-negative) and Staphylococcus aureus (gram-positive) microbes. The relationship between 
the chemical structure of the synthesized complexes and their biological influence as antimicrobial drugs was 
studied and evaluated. 
  




Nicotine (3-((2S)-1-methylpyrrolidin-2-yl)pyridine, Scheme 1) is a bicyclic chiral alkaloid with 
a pyridine and a pyrrolidine cycles, possessing an asymmetric carbon and existing as two 
enantiomeric compounds (Scheme 1). Naturally, nicotine only exists in the S shape and is found 
in Solanaceae night shade family plants such as Nicotiana rustica, Nicotiana tabacum, Duboisia 
hopwoodii and Asclepias syriaca [1]. It functions as a potent parasympathomimetic, stimulant 
drug, antiherbivore chemical, antagonist, nicotinic acetylcholine receptor agonist, insecticide 
and it is widely used as highly addictive unless used in slow-release forms [2-4]. 
 By searching in the literature survey, a number of crystal structures of metal complexes of 
nicotine had been previously prepared and their three-dimensional structures were elucidated 
using single crystal X-ray crystallography technique [5-26]. In most of these structures, nicotine 
acts a monodentate ligand, coordinated via the pyridine nitrogen [5-26]. The quantum-
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mechanical calculations provided information on the energetic of the possible interaction modes 
of copper(II), zinc(II), and cobalt(II) chiral supramolecular metal complexes of (S)-(-)-nicotine 
[5-26]. Novel metal La(II), Pr(III), Nd(IV), palladium(II), and mercury(II) complexes of 
nicotine were synthesized and their plausible chemical structures were exhaustively 
characterized using X-ray diffraction, circular dichroism, and nuclear magnetic resonance 
spectroscopic methods [5-26]. At present, there is a tendency in searching for anticancer 
substances in natural sources are usually supposed to be fewer toxic and produce negligible side 
possessions. Medications from ordinary sources have been used conventionally for thousands of 
ages in many places of the world. Experts have embattled numerous traditional or common 






Scheme 1. Chemical structure of nicotine (NIC). 
  
 Research interest on the interactions of bioactive ligands with different metal ions have been 
increased during the last decade in my laboratory [27-41]. Recently, the experimental 
protonation and complex formation equilibrium constants of nicotine (NIC) with trivalent 
(iron(III), and chromium(III)) and divalent (copper(II), and nickel(II)) metal ions have been 
investigated in aqueous solutions using pH-potentiometric, and cyclic voltammetry techniques 
[42]. In the present work, a number of binary nicotine complexes were synthesized and fully 
characterized using detailed structural and spectroscopic analysis techniques. The cytotoxic 
activities of the binary nicotine metal complexes were tested and evaluated against some tumor 
cell lines. The antioxidant activities were examined by free radical scavenging assay. As well, 
the antimicrobial assay was done against Escherichia coli (gram-negative) and Staphylococcus 
aureus (gram-positive). The relationship between the chemical structure of the synthesized 




Synthesis of binary metal - nicotine complexes 
 
A series of different binary nicotine complexes were synthesized according to the following 
general procedure: an methanolic solution (20 mL) of different metal salts (0.1 M) was added 
gradually to methanolic solution (20 mL) of nicotine (NIC (0.2 M), and stirred carefully and 
refluxed at185 oC for 6 h till the reaction was completed. Dehydrated the product by placing the 
resulting reaction mixture into a fume cupboard, leading to the isolation of solid precipitated 
complex products. Later they were filtered off, washed thoroughly with diethyl ether and 
ethanol mixture several times to remove any traces of unreacted starting materials and finally 
dried in a vacuum desiccator over fused CaCl2. Yield: 35-55%. For the binary nicotine (NIC) 
complexes, the preparation ratios (TL: TM = 2:1, L = nicotine (NIC), M (metal ion)). 
 
Physical measurements of the synthesized nicotine complexes 
 
Elemental analyses (carbon, hydrogen and nitrogen) of the binary complexes were performed on 
a Thermo Scientific™ Flash 2000 Series CHNS/O Analyzer at Precision Instrumentation 
Center, College of Science, National Taiwan University, Taipei, Taiwan. Melting points of all 
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the binary complexes were determined in open glass capillaries and were recorded on a Fisher 
Johns melting point apparatus. A Digital Elico Conductivity Bridge meter (Model No. CM-180) 
was used to measure the molar conductance of the free ligands and the metal binary complexes 
in DMSO solutions with a concentration of about 1 × 10−3 M at room temperature, using a dip-
type conductivity cell fitted with a platinum electrode. Magnetic susceptibility measurements of 
the powdered binary complexes were measured at room temperature with a Magway MSBMk1 
magnetic susceptibility balance using Hg[Co(NCS)4] as the calibrant. Magnetic measurements 
were carried out according to the Gauy method. The calculations were evaluated by applying the 




                                                                                 (1) 
   =                                                                                        (2) 
     = 2.828√                                                                             (3) 
where x is mass susceptibility per g of sample; c is the calibration constant; R is the balance 
reading for the sample and tube; R0 is the balance reading for the empty tube; M is the weight of 
the sample in g. The metal content of the complexes was determined by a Buck Scientifics 
210VGP Atomic Absorption Spectrophotometer. 
 
Spectroscopic and structural measurements of the synthesized nicotine complexes 
 
Vibration infrared spectral (IR) studies of all synthesized binary metal nicotine (NIC) complexes 
were recorded on a Shimadzu FT-IR 8000 spectrophotometer using KBr disc medium in the 
range 400–4000 cm−1 and the spectra were collected with a resolution of 2 cm−1 with 15 scans. 
The proton 1H NMR and 13C NMR spectra of the binary complexes were recorded on a JEOL 
GSX 400 MHz FT-NMR spectrometer employing TMS as internal reference to 0.0 ppm, and 
DMSO-d6 as solvent with a field gradient operating at 500.13 MHz for proton observation, and 
the measurements were done at a probe temperature of about 298 K. Fast atomic bombardment 
mass spectra (FAB-MS) of nicotine (NIC), and their metal complexes were recorded on a JEOL 
SX-102 FAB mass spectrometer using 3-nitrobenzoyl alcohol matrix. Scanning electron 
microscope (SEM) images were obtained using a JEOL JEM-1200 EX II Electron microscope at 
an acceleration voltage of 25 kV. Micro-Raman Spectrometer analysis system (Raman RS-
2000) with laser source (wavelength = 532 nm) at UniNanoTech/UniD2G (National Taiwan 
University of Science and Technology) was used to analyze the synthesized solid complexes. 
Thermogravimetric analysis (TGA) and differential thermal analysis (DTA) measurements of 
the binary complexes were conducted using Shimadzu (DSC-50 model) thermal analyzer in 
dynamic nitrogen atmosphere at a flow rate of 20 mL min−1 with a heating rate of 20 oC/min 
starting from room temperature to 1000 oC.  
 
Cytotoxic and antioxidant activities 
 
Cytotoxic and antioxidant behavior of NIC and its synthesized complexes were in vitro assayed 
and quantitative estimated statistically using SPSS 17.0 statistical software package as done 
previously in our recent published work based on the experimental measurements used for 




The potency of nicotine metal complexes as antimicrobial agent was tested against a gram 
positive microorganism Staphylococcus aureus and a gram negative microorganism Escherichia 
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coli. Broth macro-dilution method was used for the determination of inhibitory activity of the 
complex. Ampicilin (895.5 μg·mL-1 potency) was used as the antibiotic reference. The complex 
was prepared at 3 concentrations (100, 1000 and 2000 μg·mL-1). The complex with the best 
inhibitory activity was then tested further to determine the minimal inhibition concentration 
(MIC50 and MIC90). The assay was performed in a tube containing the tested compound 
dissolved in Lysogeny Broth (LB) media which was prepared from the mixture of tryptone, 
yeast extract and sodium chloride with a ratio of 2:1:2 w/w/w. Fifteen micro-liters of the 
prepared bacteria suspension (1x108 cfu·mL-1) were injected to the test tube. After incubated for 
24 h at 37 oC, the OD600nm of each sample was measured. As the growth control, 15 μL of 
bacteria suspension was injected into the test tube containing no sample. The antimicrobial 
activity was expressed as %inhibition as shown in the following equation: 
%inhibition = ([Ic – Is]/Ic) ×100                                                                                 (4) 
where (Ic) is the absorbance of control and (Is) is the absorbance of sample at 600 nm. 
 
RESULTS AND DISCUSSION  
 
Physical and chemical characterizations  
 
Different metal – NIC binary complexes have a reported melting points ranging from 270 oC to 
310 oC. The molar conductivity values for the synthesized complexes (1.0 × 10−3 mol/cm3) were 
found between 57 and 98 Ω−1cm2mol−1 suggesting a moderate electrolytic nature, and provide a 
method of testing the degree of ionization of the complexes. These results were strongly 
supported by the elemental analysis data. The magnetic susceptibilities (µeffe) of the synthesized 
complexes at room temperature were found to be consistent with low spin distorted octahedral 
structures. The elucidation molecular structures of the synthesized nicotine complexes were 
confirmed by detailed spectroscopic IR, Raman and NMR techniques. The synthesized 
complexes were found to be stable at room temperature with different colors, and partially 
soluble in D2O, soluble in DMSO and DMF solvents. The proposed coordination modes of the 
resulted complexes are dependent on the routine spectral analysis. 
 
Infrared and NMR spectral analysis  
 
The essential infrared and Raman spectral absorption patterns of the synthesized complexes are 
shown in Figures 1, 2 and 3. Careful inspection of the IR spectra of free nicotine (NIC) ligand 
and its synthesized binary complexes was made in order to facilitate the assignment of these 
bands in the free ligand and its metal complexes as shown in the IR charts. It was concluded that 
there is no straight regularity in the change of wavenumbers of the analyzed bands along with 
the position of the nitrogen atom in the aromatic ring. That means, electronic charge distribution 
of the whole molecule differs depending on the position of the nitrogen in the ring in the 
presence of metal ions. The nuclear magnetic resonance 1H NMR and 13C NMR spectra of free 
nicotine (NIC) ligand and its synthesized metal complexes recorded in DMSO-d6 taking TMS as 
internal standards could be found in Figures 4 and 5. From the proton and carbon assignments 
for the free nicotine (NIC) ligand and its synthesized metal complexes, the comparison between 
peaks of free ligand and their complexes appeared clearly, in which there are blue shifted in the 
assignments values of protons and carbons because of the metal-ligand complex formation. 
 
Scanning electron microscope (SEM) analysis  
 
The scanning electron micrographs (SEM) at various magnifications of the synthesized binary 
metal-nicotine complexes show the layered structure, surface morphology, and microstructure of 
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the studied complexes as in the typical scanning electron micrographs shown in Figure 6. The 
surface morphology of SEM micrograph reveals the well sintered nature of the complexes with 
variant grain sizes and shapes. The distribution of grain size is homogeneous for most 
complexes, and it is clear that very small grains are obtained with agglomerates for different 
Fe(III), Cu(II), Bi(II), Ni(II), and Zn(II) complexes of nicotine (NIC). The particle size 
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Raman shift (Cm-1)
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Figure 6. SEM images of MoNic, BiNic, NiNic, ZnNic, HgNic, MnNic, AlNic, VNic, MgNic, 
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Nicotine metal complexes
Thermogravimetric analysis  
 
Thermogravimetric analyses of the synthesized nicotine complexes were conducted in from 30 
to 600 oC. The thermograms are shown in Figure 7. The initial mass loss which 
until 200 oC corresponds to the 
metal-nicotine complexes, the mass loss from 220 to 310 
ligand NIC thus residue at above 380 
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loss of water and ethanol molecules. For most of the synthesized 
oC corresponds to decomposition of 
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Figure 7. Thermograms of MoNic, BiNic, NiNic, ZnNic, HgNic, and MnNic, binary complexes.
 
Cytotoxicity’s of nicotine and its metal complexes
 
When nicotine enters the body, it is distributed quickly through 
blood–brain barrier reaching the 
of nicotine in the body is around two hours. The amount of nico
smoking may depend on many factors, including the types of tobacco, whether the smoke is 
inhaled, and whether a filter is used. However, it has been found that the nicotine yield of 
MnNic 
HgNic 
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blood stream and crosses the 
brain within 10–20 s after inhalation. The elimination half
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individual products has only a small effect (4.4%) on the blood concentration of nicotine 
suggesting "the assumed health advantage of switching to lower-tar and lower-nicotine 
cigarettes may be largely offset by the tendency of smokers to compensate by increasing 
inhalation". Nicotine is metabolized in liver by cytochrome P450 enzymes (mostly CYP2A6, 
and also by CYP2B6). A major metabolite is cotinine. Other primary metabolites include 
nicotine N'-oxide, nornicotine, nicotine isomethonium ion, 2-hydroxynicotine and nicotine 
glucuronide under some conditions. Glucuronidation and oxidative metabolism of nicotine to 
cotinine are both inhibited by menthol, an additive to mentholated cigarettes, thus increasing the 
half-life of nicotine in vivo. Nicotine as a biomarker is very important for quantifying human 
exposure to environmental tobacco smoke (ETS) and for predicting potential health risks for 
exposed individuals. Passive smoking is a real and significant threat to public health. The first 
step is the promotion of effective measures protecting from indoor exposure to tobacco smoke at 
the workplace, in public transport, and other public places. In the same manner, as stated before, 
almost all nitrogen and oxygen donor ligands showed a lot of significant biological applications. 
In the present work, we examined the cytotoxicity's of nicotine and their binary complexes with 
molybdenum(IV), bismuth(III), nickel(II), zinc(II), mercury(II), manganese(II), aluminum(III), 
 vanadium(V), magnesium(II), and copper(II)  metal ions against: HepG2 (human hepatocellular 
carcinoma), HPC3 (human prostate cancer), and HCT116 (human colorectal carcinoma) tumor 
cell lines. From the results obtained (Table 1), it is possible to conclude that the complexes 
studied (under physiological conditions), namely, the nature of nicotine ligand (e.g., the number 
of N atoms), the characteristics of the leaving groups at some metal ions, the number and 
coordination mode of the metal ions, and their chemical environment, determine their 
bioactivities, most probably through induction of DNA structural rearrangements. Thus, the 
design of new, more effective bioactive drugs should be governed by these crucial factors, since 
slight changes in the metal coordination are sufficient to significantly change the in vitro 
antiproliferative and/ or cytotoxic properties of these complexes. Among the complex species 
tested against the three human cancer cell lines, i.e.:HepG2 (human hepatocellular carcinoma), 
HPC3 (human prostate cancer), and HCT116 (human colorectal carcinoma) tumor cell lines 
(Table 1), it was observed that: (i) The nicotine complexes involving molybdenum(IV), 
bismuth(III), nickel(II), manganese(II), and magnesium(II) metal ions showed very strong 
cytotoxic activities against HepG2 , HPC3, and HCT116 tumor cell lines. (ii) The nicotine 
complexes of nickel(II), mercury(II), and copper(II) metal ions showed weak activities against 
HepG2 , HPC3 , and HCT116 tumor cell lines. (iii) Zinc(II), and vanadium(V) complexes of 
nicotine exhibited weak cytotoxic activities, while manganese(II), and aluminum(III) complexes 
of nicotine exhibited a moderate activity against HepG2 cancer cell line. (iv) Zinc(II), and 
magnesium(II) complexes of nicotine exhibited a strong activity against HPC3 cancer cell line. 
(v) Aluminum(III), vanadium(V) and copper(II) complexes of nicotine exhibited a very weak 
activity against HPC3 cancer cell line. (vi) Aluminum(III), vanadium(V) and zinc(II) complexes 
of nicotine exhibited moderate activities against HCT116 tumor cell line. 
 
Antioxidant activities of the synthesized nicotine metal complexes 
 
Antioxidant activity is one of the important standard assays in pharmaceutical to examine the 
potency of a compound to inhibit the formation of free radical. 2,2-Diphenyl-1-picrylhydrazyl 
(DPPH) is a popular “stable free-radical” for antioxidant assay. DPPH has an unpaired electron 
at one atom of Nitrogen Bridge. It was known that, nicotine (Nic) displays numerous 
pharmacological and therapeutic applications, as well, metal ions play a crucial role in various 
enzymes that catalyze oxidation/reduction reactions correlated with the antioxidant system of 
the organism concerned. However, the different behavior depends upon the chemical 
environment and the nature of the chelating agent. In the present work, molybdenum(IV), 
bismuth(III), nickel(II), zinc(II), mercury(II), manganese(II), aluminum(III),  vanadium(V), 
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magnesium(II), and copper(II)  metal-nicotine complexes were subjected to DPPH radical 
scavenging measurements (Table 2). By looking at the data listed in Table 2, we can conclude 
that most metal nicotine complexes displayed a moderate antioxidant activity. 
 




Cancer cell linea/IC50 (μg/mL)
b 
 HEPG-2 HPC3 HCT116 
MoNic 0.0162 ± 0.005 0.361± 0.054 0.355± 0.052 
BiNic 0.0279 ± 0.006 0.034± 0.006 0.0884± 0.001 
NiNic 227.48 ± 13.124 83.87± 7.679 127.4112± 11.21 
ZnNic 32.954± 3.454 0.1143± 0.007 2.4004± 0.410 
HgNic 80.42 ± 5.460 62.23± 6.176 36.65± 5.654 
MnNic 2.125 ± 0.254 1.200 ± 0.012 0.8915± 0.100 
AlNic 7.503 ± 1.464 56.91± 7.665 6.524± 1.740 
VNic 28.47 ± 2.604 53.66± 5.156 1.66± 0.188 
MgNic 0.104 ± 0.034 0.0104± 0.006 0.0121± 0.004 
CuNic 14.532 ±0.124 3009.03± 54.543 28.656± 4.016 
aThe IC50 value is the molarity at which 50% of tumor cell death was observed after 72 h under standard 
tissue culture conditions. Each experimental variable was run three times, and the results were expressed 
via mean value and standard deviation. A two-tailed p value of less than 0.05 was considered to be 
statistically significant. bCancer cell lines: HepG2 (human hepatocellular carcinoma), HPC3 (human 
prostate cancer), and HCT116 (human colorectal carcinoma) tumor cell lines.  
 
Table 2. DPPH radical scavenging assay of nicotine metal complexes. 
 
Nicotine complexes DPPH inhibition (%) 
MoNic 57.6 ± 3.5 
BiNic 35.5 ± 3.6 
NiNic 51.3 ± 2.3 
ZnNic 68.6 ± 2.4 
HgNic 44.7 ± 2.3 
MnNic 45.5 ± 3.5 
AlNic 23.6 ± 4.1 
VNic 56.4 ± 3.8 
MgNic 53.6 ± 3.2 
CuNic 34.2 ± 2.2 
 
Microbial growth inhibitory activities of the synthesized nicotine metal complexes  
 
Antimicrobial assays against several microorganisms such as Escherichia coli, Staphylococcus 
aureus, Bacillus subtilis, and Candida albicansis are usually conducted to examine the 
antimicrobial potency of the complex. In this study, the antimicrobial assay was done against E. 
coli (gram-negative) and S. aureus (gram-positive). Severe E. coli infection may causes bloody 
diarrhea leading to kidney failure, while S. aureus infection especially in the bloodstream may 
lead to sepsis (life-threatening low blood pressure) [43]. Microbial growth inhibitory activity or 
antimicrobial activity of nicotine and its metal complexes were studied against the Escherichia 
coli and Staphylococcus aureus by broth macro dilution method in lysogeny broth media. 
Commercial antibiotic ampicillin was used as the standard reference. From the data shown in 
Table 3, Nic was shown to have a moderate antimicrobial activity against the two tested bacteria. 
Such outcome is probably due to the structure of the ligand NIC that is consists of nitrogen atoms 
which act as the nutrient source for the bacteria. 
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For the synthesized complexes, some exhibited smaller antimicrobial activity than that of the 
ligand. Antimicrobial activities of the synthesized binary nicotine complexes are given in Table 
3. Antimicrobial activity of the complexes follows the order: Zinc > nickel > copper > 
magnesium > molybdenum > aluminum > vanadium > mercury > bismuth. It is worthwhile to 
diagnose the efficacy of molybdenum nicotine complex by determining the MIC (minimum 
inhibitory concentration) which is the lowest concentration of an antimicrobial agent that is able 
to inhibit the visible growth of a microorganism after overnight incubation [44].  
Table 3. Antimicrobial activity of the synthesized binary complexes. 
 
Complex species 
Concentration %Inhibition ± SD 
(μg/mL) E. coli  S. aureus 
Ampicilin 
(Standard control) 
100 59.8 ± 2.0  99.3 ± 0.1 
 1000 99.6 ± 0.1  99.7 ± 0.0 
 2000 100.0 ± 0.0  100.0 ± 0.0 
Nic 100 12.3 ± 0.1  14.5 ± 1.5 
 1000 43.1 ± 2.4  38.5 ± 2.8 
 2000 57.7 ± 3.6  61.3 ± 1.2 
MoNic 100 14.8 ± 1.2  17.5 ± 1.8 
 1000 23.6 ± 1.3  22.4 ± 3.0 
 2000 61.1 ± 3.9  66.7 ± 3.1 
BiNic 100 13.1 ± 1.6  12.5 ± 1.7 
 1000 19.4 ± 2.2  25.9 ± 2.3 
 2000 49.6 ± 3.1  49.3 ± 3.1 
NiNic 100 23.6 ± 1.3  34.2 ± 1.1 
 1000 65.5 ± 1.8  45.6 ± 4.6 
 2000 76.6 ± 2.2  73.7 ± 4.3 
ZnNic 100 39.8 ± 1.2  33.5 ± 1.3 
 1000 56.3 ± 3.5  53.8 ± 1.6 
 2000 91.2 ± 6.2  83.9 ± 3.8 
HgNic 100 12.0 ± 1.3  21.2 ± 1.8 
 1000 43.5 ± 2.2  36.4 ± 2.5 
 2000 55.9 ± 3.6  46.7 ± 3.5 
AlNic 100 23.1 ± 1.8  21.5 ± 1.7 
 1000 42.4 ± 2.6  37.9 ± 3.4 
 2000 69.6 ± 3.1  55.3 ± 6.1 
VNic 100 21.6 ± 2.1  19.2 ± 1.1 
 1000 35.5 ± 3.0  25.4 ± 2.6 
 2000 66.6 ± 3.2  54.7 ± 3.3 
MgNic 100 23.6 ± 2.1  21.2 ± 2.1 
 1000 35.5 ± 0.8  35.4 ± 3.6 
 2000 66.6 ± 1.2  63.7 ± 4.3 
CuNic 100 16.6 ± 1.1  13.2 ± 1.1 
 1000 38.5 ± 2.8  35.8 ± 2.6 
 2000 75.6 ± 4.2  73.9 ± 3.3 
 
In this work, minimum compound concentrations that inhibited 50% (MIC50) and 90% 
(MIC90) of the bacteria were determined. MICs of ligand NIC, and its zinc complex were 
determined and the results are shown in Table 4. Complexes of zinc showed higher inhibition 
activity than that of ligand Nic alone (especially against gram positive bacteria, S. aureus) as 
shown by smaller MIC50 and MIC90 values. The Nic complexes were found to be more effective 
toward gram positive bacteria than to gram negative bacteria, possibly due to difference in their 
cell walls [45, 46]. As gram positive bacteria, S. aureus cell wall consists of thick peptidoglycan 
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layer and plasma membrane; as gram negative bacteria, E. coli cell wall possesses an extra layer 
(outer membrane layer) which is high in lipid. This lipid containing membrane limits the ability 
of the chelate complex to permeate into the bacteria inner membrane thus lowering the inhibition 
activity. 
Table 4. MIC (μg/mL) of the tested compounds. 
 
Compound E. coli  S. aureus 
 MIC50 MIC90  MIC50 MIC90 
Ampicilin 4.4 52.3  0.5 2.9 
Nic >2000 >2000  >2000 >2000 




The synthesis of the complexes between nicotine and essential metal ions were studied to 
investigate the complexation behavior of these systems as it could mimic many biological 
interactions of the. The complexes appear to be superior in biological properties to ligand alone. 
The complete elucidation molecular structures of the synthesized binary nicotine complexes 
were confirmed by detailed spectroscopic IR, Raman, NMR, and SEM techniques. The 
complexes were found to increase the cytotoxic, antioxidant, and antimicrobial activity of the 
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